Crossmark

Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study

Crossref DOI link: https://doi.org/10.1186/s12885-019-6237-5

Published Online: 2019-10-22

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ren, Yanqiao

Cao, Yanyan

Ma, Hong

Kan, Xuefeng

Zhou, Chen

Liu, Jiacheng

Shi, Qin

Feng, Gansheng

Xiong, Bin

Zheng, Chuansheng
Funding

Funding for this research was provided by:

National Nature Science Fundation of China (81471766 and 81873917)
License Information

Text and Data Mining valid from 2019-10-22

Version of Record valid from 2019-10-22
More Information

Article History

Received: 15 June 2019

Accepted: 1 October 2019

First Online: 22 October 2019

Ethics approval and consent to participate

: This retrospective study was approved by the institutional review board of the Union Hospital, Tongji Medical college, Huazhong University of Science and Technology. Written informed consent was obtained from all patients prior to treatment.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below